Fundz

Elixirgen Therapeutics reported raising $3.6 Million in an initial SEC Form D filing, from an offering of $3.6 Million

PRIVATEApr 09, 2025

Amount Raised

$3.6 Million

$3.6 Million sold, per SEC Form D (first sale Mar 31, 2025)

Round Type

Seed

BaltimoreBiotechnology

Who to call at Elixirgen Therapeutics, and when

A new round usually means Elixirgen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elixirgen Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elixirgen Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elixirgen Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elixirgen Therapeutics

Location

855 N. WOLFE ST.

Baltimore, Maryland, United States

About

Elixirgen Therapeutics is a biotechnology company advancing its controllable self-replicating RNA technology to develop therapies for a broad spectrum of diseases, including rare diseases, aging-related disorders, and cancer. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elixirgen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNaonori K., Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Elixirgen Therapeutics's next move

See what Strategic adds

Elixirgen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.